CDHA CAAR

February 3, 2016

CAAR – Lancet Oncology Article Abstract – February 3, 2016

Filed under: Reports and Articles — Tags: — admin @ 4:41 pm

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study,” by Neal D. Shore, Simon Chowdhury, Arnauld Villers, Laurence Klotz, D. Robert Siemens, De Phung, Steve van Os, Nahla Hasabou, Fong Wang, Suman Bhattacharya, and Axel Heidenreich (Vol. 17, No. 2, February 2016, p. 153-163).

www.lancet.com/journals/lanonc/article/PIIS1470-2045%2815%2900518-5/abstract

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress